Safran SA - SAF.PA

SAF.PA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
SAF.PA	1.5	3.6	6.2	5.7	14.2	33.0	102.9	60.0	304.8	1943.1
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare SAF.PA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	SAF.PA
name	Safran SA
price	227.4
changes percentage	1.5179
change	3.4
day low	225
day high	227.8
year high	228.6
year low	164.5
market cap	94769212647
price avg 50	216.086
price avg 200	207.55525
exchange	EURONEXT
volume	728695
avg volume	597776
open	225.5
previous close	224
eps	3.94
pe	57.72
earnings announcement	2025-02-14T10:59:00.000+0000
shares outstanding	416751155
timestamp	2025-01-17 16:35:19

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 54.3%

Overall Quarterly Financial Health: 56.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	23651000000	19523000000	21.14
gross profit	11211000000	2189000000	412.15
gross profit ratio	0.47	0.11	322.76
research and development expenses	1216000000	1219000000	-0.25
operating expenses	8413000000	159000000	5191.19
interest income	230000000	38000000	505.26
interest expense	140000000	99000000	41.41
ebitda	4411000000	-2030000000	317.29
ebitdaratio	0.19	0.17	7.06
operating income	2798000000	2030000000	37.83
operating income ratio	0.12	0.1	13.78
net income	3444000000	-2459000000	240.06
net income ratio	0.15	-0.13	215.61
eps	8.33	-5.76	244.62

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 23,651 million in 2023 from 19,523 million in 2022 representing a change of 21.14%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 11,211 million in 2023 from 2,189 million in 2022 representing a change of 412.15%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 4,411 million in 2023 from -2,030 million in 2022 representing a change of 317.29%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 2,798 million in 2023 from 2,030 million in 2022 representing a change of 37.83%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,444 million in 2023 from -2,459 million in 2022 representing a change of 240.06%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 8.33 in 2023 from 8.33 in 2022 representing a change of 244.62%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1,216 million in 2023 from 1,219 million in 2022 representing a change of -0.25%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 8,413 million in 2023 from 159 million in 2022 representing a change of 5191.19%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	13292000000	12522000000	6.15
gross profit	6646000000	1632000000	307.23
gross profit ratio	0.5	0.13	283.64
research and development expenses	909000000	743000000	22.34
operating expenses	4702000000	15000000	31246.67
interest income	141000000	85000000	65.88
interest expense	67000000	0	NaN
ebitda	2758000000	2859000000	-3.53
ebitdaratio	0.21	0.18	12.97
operating income	1944000000	1617000000	20.22
operating income ratio	0.15	0.13	13.26
net income	57000000	1581000000	-96.39
net income ratio	0.0	0.13	-96.60
eps	0.13	3.81	-96.59

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 13,292 million in 2024Q2 from 12,522 million in 2023Q4 representing a change of 6.15%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 6,646 million in 2024Q2 from 1,632 million in 2023Q4 representing a change of 307.23%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 909 million in 2024Q2 from 743 million in 2023Q4 representing a change of 22.34%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 1,944 million in 2024Q2 from 1,617 million in 2023Q4 representing a change of 20.22%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 57 million in 2024Q2 from 1,581 million in 2023Q4 representing a change of -96.39%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 4,702 million in 2024Q2 from 15 million in 2023Q4 representing a change of 31246.67%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 2,758 million in 2024Q2 from 2,859 million in 2023Q4 representing a change of -3.53%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 0.13 in 2024Q2 from 0.13 in 2023Q4 representing a change of -96.59%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	50468000000	46828000000	7.77
total liabilities	38380000000	35962000000	6.72
total equity	12088000000	10866000000	11.25
cash and cash equivalents	6676000000	6687000000	-0.16
short term investments	0	242000000	-100.00
long term investments	753000000	2752000000	-72.64
total current assets	29375000000	24121000000	21.78
total non current assets	21846000000	22707000000	-3.79
total current liabilities	30787000000	27427000000	12.25
total non current liabilities	7593000000	8535000000	-11.04
common stock	85000000	85000000	0.00
retained earnings	3444000000	5199000000	-33.76
total debt	6582000000	6949000000	-5.28

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 50,468 million in 2023 from 46,828 million in 2022 representing a change of 7.77%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 12,088 million in 2023 from 10,866 million in 2022 representing a change of 11.25%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 29,375 million in 2023 from 24,121 million in 2022 representing a change of 21.78%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 6,582 million in 2023 from 6,949 million in 2022 representing a change of -5.28%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 38,380 million in 2023 from 35,962 million in 2022 representing a change of 6.72%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 6,676 million in 2023 from 6,687 million in 2022 representing a change of -0.16%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 242 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 30,787 million in 2023 from 27,427 million in 2022 representing a change of 12.25%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 3,444 million in 2023 from 5,199 million in 2022 representing a change of -33.76%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	53015000000	50468000000	5.05
total liabilities	41288000000	38380000000	7.58
total equity	11727000000	12599000000	-6.92
cash and cash equivalents	5699000000	6676000000	-14.63
short term investments	225000000	470000000	-52.13
long term investments	2381000000	1928000000	23.50
total current assets	30176000000	28622000000	5.43
total non current assets	23694000000	21846000000	8.46
total current liabilities	34116000000	28120000000	21.32
total non current liabilities	7172000000	10260000000	-30.10
common stock	85000000	85000000	0.00
retained earnings	6759000000	3444000000	96.25
total debt	5099000000	6302000000	-19.09

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 53,015 million in 2024Q2 from 50,468 million in 2023Q4 representing a change of 5.05%. Suggesting a growth in asset holdings.

  Total Current Assets: Total Current Assets increased to 30,176 million in 2024Q2 from 28,622 million in 2023Q4 representing a change of 5.43%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 6,759 million in 2024Q2 from 3,444 million in 2023Q4 representing a change of 96.25%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 5,099 million in 2024Q2 from 6,302 million in 2023Q4 representing a change of -19.09%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 41,288 million in 2024Q2 from 38,380 million in 2023Q4 representing a change of 7.58%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 11,727 million in 2024Q2 from 12,599 million in 2023Q4 representing a change of -6.92%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 5,699 million in 2024Q2 from 6,676 million in 2023Q4 representing a change of -14.63%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 225 million in 2024Q2 from 470 million in 2023Q4 representing a change of -52.13%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 34,116 million in 2024Q2 from 28,120 million in 2023Q4 representing a change of 21.32%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-11000000	1440000000	-100.76
operating cash flow	4270000000	3545000000	20.45
free cash flow	3438000000	2949000000	16.58
capital expenditure	-874000000	-596000000	-46.64
depreciation and amortization	1336000000	1371000000	-2.55
deferred income tax	308000000	-4319900000	107.13
stock based compensation	64200000	32900000	95.14
accounts payables	-2252000000	-2370000000	4.98
inventory	-1494000000	-1545000000	3.30
acquisitions net	-126000000	-242000000	47.93
investments in property plant and equipment	-832000000	-596000000	-39.60
net cash used for investing activites	-1704000000	-1288000000	-32.30
debt repayment	-455000000	-320000000	-42.19
common stock issued	2000000	0	NaN
common stock repurchased	-1535000000	-270000000	-468.52
dividends paid	-564000000	-213000000	-164.79
net cash used provided by financing activities	-2576000000	-815000000	-216.07
cash at end of period	6676000000	6687000000	-0.16
accounts receivables	2551000000	2370000000	7.64
cash at beginning of period	6687000000	5247000000	27.44

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -11 million in 2023 from 1,440 million in 2022 representing a change of -100.76%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Deferred Income Tax: Deferred Income Tax increased to 308 million in 2023 from -4,320 million in 2022 representing a change of 107.13%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 64 million in 2023 from 33 million in 2022 representing a change of 95.14%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 2,551 in 2023 from 2,370 million in 2022 representing a change of 7.64%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -564 million in 2023 from -213 million in 2022 representing a change of -164.79%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 4,270 million in 2023 from 3,545 million in 2022 representing a change of 20.45%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 3,438 million in 2023 from 2,949 million in 2022 representing a change of 16.58%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -874 million in 2023 from -596 million in 2022 representing a change of -46.64%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 2,252 million in 2023 from 2,370 million in 2022 representing a change of 4.98%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	2220000000	2207000000	0.59
free cash flow	1704000000	1600000000	6.50
capital expenditure	-516000000	-607000000	14.99
depreciation and amortization	914000000	683000000	33.82
deferred income tax	0	308000000	-100.00
stock based compensation	33000000	36100000	-8.59
accounts receivables	1316000000	1254000000	4.94
accounts payables	0	-1254000000	100.00
inventory	-1297000000	-475000000	-173.05
acquisitions net	0	-181000000	100.00
investments in property plant and equipment	-516000000	-607000000	14.99
net cash used for investing activites	-985000000	-889000000	-10.80
debt repayment	-742000000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-574000000	-604000000	4.97
dividends paid	-911000000	0	NaN
net cash used provided by financing activities	-2232000000	-787000000	-183.61
net change in cash	5699000000	529000000	977.32
cash at end of period	5699000000	6676000000	-14.63
cash at beginning of period	0	6147000000	-100.00

Overall Score of Quarterly Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 5,699 million in 2024Q2 from 529 million in 2023Q4 representing a change of 977.32%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 2,220 million in 2024Q2 from 2,207 million in 2023Q4 representing a change of 0.59%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,704 million in 2024Q2 from 1,600 million in 2023Q4 representing a change of 6.5%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 33 million in 2024Q2 from 36 million in 2023Q4 representing a change of -8.59%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q2 from 1,254 million in 2023Q4 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -516 million in 2024Q2 from -607 million in 2023Q4 representing a change of 14.99%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 1,316 in 2024Q2 from 1,254 million in 2023Q4 representing a change of 4.94%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -911 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q2 2022 Earnings call transcript
Q4 2021 Earnings call transcript
Q2 2021 Earnings call transcript
Q4 2020 Earnings call transcript
Q2 2020 Earnings call transcript
Q4 2019 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	56.61	45.76	23.72
net income per share	8.24	-5.76	243.04
operating cash flow per share	10.22	8.31	23.01
free cash flow per share	8.23	6.91	19.06
cash per share	15.98	16.24	-1.60
book value per share	28.93	25.47	13.61
tangible book value per share	-1.07	-16.92	93.66
shareholders equity per share	27.71	24.4	13.56
interest debt per share	16.09	16.52	-2.60
market cap	66880702359.36	49887502416.44	34.06
enterprise value	66786702359.36	50149502416.44	33.18
pe ratio	19.42	-20.29	195.72
price to sales ratio	2.83	2.56	10.66
pocfratio	15.66	14.07	11.30
pfcf ratio	19.45	16.92	14.99
pb ratio	5.78	4.79	20.56
ptb ratio	5.78	4.79	20.56
ev to sales	2.82	2.57	9.93
enterprise value over ebitda	15.14	-24.7	161.29
ev to operating cash flow	15.64	14.15	10.56
ev to free cash flow	19.43	17.01	14.23
earnings yield	0.05	-0.05	204.47
free cash flow yield	0.05	0.06	-13.04
debt to equity	0.57	0.67	-14.82
debt to assets	0.13	0.15	-12.11
net debt to ebitda	-0.02	-0.13	83.49
current ratio	0.95	0.88	8.49
interest coverage	19.99	20.51	-2.53
income quality	1.24	-1.44	186.00
dividend yield	0.01	0.0	97.51
payout ratio	0.16	-0.09	289.06
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.05	0.06	-17.66
intangibles to total assets	0.25	0.39	-35.68
capex to operating cash flow	0.2	0.17	21.75
capex to revenue	0.04	0.03	21.05
capex to depreciation	0.65	0.43	50.49
stock based compensation to revenue	0.0	0.0	61.08
graham number	71.69	56.25	27.45
roic	0.09	0.07	28.11
return on tangible assets	0.09	-0.09	206.13
graham net net	-50.28	-45.37	-10.84
working capital	-1412000000	-3306000000	57.29
tangible asset value	-448000000	-7218000000	93.79
net current asset value	-9005000000	-11841000000	23.95
invested capital	15827000000	19191000000	-17.53
average receivables	8486500000	7333000000	15.73
average payables	3698000000	2729000000	35.51
average inventory	7641500000	6616500000	15.49
days sales outstanding	138.77	149.21	-7.00
days payables outstanding	125.81	65.44	92.24
days of inventory on hand	231.88	155.4	49.22
receivables turnover	2.63	2.45	7.52
payables turnover	2.9	5.58	-47.98
inventory turnover	1.57	2.35	-32.98
roe	0.3	-0.24	225.95
capex per share	2.09	1.4	49.76

• Positive

  ROE: Return on Equity (ROE) increased to 0.30 on 2023-12-31 from -0.24 on 2022-12-31, representing a change of 225.95%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 19.42 on 2023-12-31 from -20.29 on 2022-12-31, representing a change of 195.72%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.57 on 2023-12-31 from 0.67 on 2022-12-31, representing a change of -14.82%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 0.95 on 2023-12-31 from 0.88 on 2022-12-31, representing a change of 8.49%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
SAF.PA
calendar year	2024	2023	NaN
revenue per share	30.89	30.19	2.32
net income per share	0.13	3.81	-96.52
operating cash flow per share	5.16	5.32	-3.04
free cash flow per share	3.96	3.86	2.66
cash per share	13.77	17.23	-20.09
book value per share	27.26	29.15	-6.49
tangible book value per share	7.03	8.38	-16.06
shareholders equity per share	26.07	29.15	-10.55
interest debt per share	12.01	15.2	-20.98
market cap	86950319087.7	66387201492.24	30.97
enterprise value	86350319087.7	66013201492.24	30.81
pe ratio	381.36	10.5	3532.82
price to sales ratio	6.54	5.3	23.39
pocfratio	39.17	30.08	30.21
pfcf ratio	51.03	41.49	22.98
pb ratio	7.75	5.49	41.13
ptb ratio	7.75	5.49	41.13
ev to sales	6.5	5.27	23.23
enterprise value over ebitda	31.31	23.09	35.60
ev to operating cash flow	38.9	29.91	30.04
ev to free cash flow	50.68	41.26	22.82
earnings yield	0.0	0.02	-97.25
free cash flow yield	0.02	0.02	-18.69
debt to equity	0.45	0.52	-12.81
debt to assets	0.1	0.12	-22.98
net debt to ebitda	-0.22	-0.13	-66.30
current ratio	0.88	1.02	-13.10
interest coverage	29.01	0	NaN
income quality	38.95	1.4	2690.02
dividend yield	0.01	0	NaN
payout ratio	15.98	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.07	0.06	15.25
intangibles to total assets	0.16	0.17	-3.83
capex to operating cash flow	0.23	0.28	-15.49
capex to revenue	0.04	0.05	-19.92
capex to depreciation	0.56	0.89	-36.48
stock based compensation to revenue	0.0	0.0	-13.88
graham number	8.82	50.0	-82.37
roic	-0.07	0.05	-244.75
return on tangible assets	0.0	0.04	-96.59
graham net net	-50.68	-49.52	-2.34
working capital	-3940000000	502000000	-884.86
tangible asset value	3026000000	3475000000	-12.92
net current asset value	-11112000000	-9758000000	-13.88
invested capital	9782000000	21648000000	-54.81
average receivables	10420000000	9934000000	4.89
average payables	6281000000	5277000000	19.03
average inventory	8623500000	7642000000	12.84
days sales outstanding	80.22	64.63	24.13
days payables outstanding	120.84	30.07	301.79
days of inventory on hand	126.54	65.31	93.74
receivables turnover	1.12	1.39	-19.44
payables turnover	0.74	2.99	-75.11
inventory turnover	0.71	1.38	-48.38
roe	0.01	0.13	-96.12
capex per share	1.2	1.46	-18.06

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-06-30 Q2 from 0.13 on 2023-12-31 Q4, representing a change of -96.12%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.88 on 2024-06-30 Q2 from 1.02 on 2023-12-31 Q4, representing a change of -13.10%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 381.36 on 2024-06-30 Q2 from 10.50 on 2023-12-31 Q4, representing a change of 3532.82%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.45 on 2024-06-30 Q2 from 0.52 on 2023-12-31 Q4, representing a change of -12.81%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 89.95 which is lower than current price 227.4, indicates the company may be overvalued.